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ABSTRACT 
Engineered nanoparticles such as iron oxide (Fe3O4) nanoparticles (IONPs) offer several 
benefits in nanomedicine, notably as contrast agents in magnetic resonance imaging (MRI). 
Ferumoxytol, a suspension of IONPs (with a manufacturer’s reported particle diameter of 27 
nm-30 nm) was characterized as a standard by spiking into rat blood plasma and cell 
fractions. Nanoparticle separation, and characterization was investigated with asymmetric 
flow field-flow fractionation (AF4) coupled online to ultraviolet-visible spectroscopy (UV-
VIS), multi-angle light scattering (MALS) and inductively coupled plasma mass 
spectrometry (ICP-MS) detectors; also with single particle inductively coupled plasma mass 
spectrometry (spICP-MS) and transmission electron microscopy (TEM). MALS signal of 
pristine Ferumoxytol indicated radii of gyration (Rg) between 15-28 nm for the Fe-containing 
fraction and 30-75 nm for the non-Fe fraction. IONPs spiked into blood plasma indicated a 
polydisperse distribution between 40 nm - 120 nm suggesting matrix-induced size alterations. 
Spiking of the IONPs into cells shows a shift in ICP-MS Fe signal to 15 min, however the 
MALS signal was undetected within the Fe containing fraction of the IONPs suggesting NP 
loss due to membrane-particle attraction. spICP-MS analysis of IONPs spiked in rat plasma 
suggested the release of Fe-containing colloids into plasma causing an increase in diameter of 
IONPs to 52± 0.8 nm; whereas no major variation in particle size and distribution of the 
IONPs spiked in cell fractions was observed (33.2 ± 2.0 nm) suggesting non-alteration of the 
NP Fe core. A complementary application of microscopic, light scattering, and mass 
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1. Introduction 
Engineered nanoparticles are particles in the size range of 1-100 nm that are designed with 
specific intended properties and purposes. They have become increasingly useful in everyday 
life with applications across diverse sectors in products such as drugs, cosmetics, 
photovoltaic cells, surface coatings etc. In healthcare, engineered metallic nanoparticles 
(EMNPs) are now increasingly important in ‘nanomedicine’ for therapeutic as well as 
diagnostic purposes (nanotheranostics) [1,2] . The need to effectively and accurately deliver 
therapeutic load to target tissues across cell membranes is challenging to meet using 
conventional drugs, necessitating the development and use of biocompatible nano-sized 
particles as an alternative approach [3]. The unique properties of EMNPs such as high surface 
area/volume ratio, high reactivity, optical properties [4], and biocompatibility make them 
ideal candidates for such applications. Superparamagnetic iron oxide nanoparticles 
(SPIONs)[5-8]  have been well studied for their use as diagnostic contrast agents for 
magnetic resonance imaging of diseased cardiovascular tissue[9], and are preferred over 
gadolinium-based contrast agents especially in certain conditions such as in patients with 
chronic kidney disease (CKD)[10,11], where better tolerances have been reported[12]. In 
addition, iron supplements are regularly administered intravenously for severe Fe deficiency 
anaemia especially in cases where oral iron supplementation is inadequate [13]. However, 
despite the obvious advantages of iron oxide nanoparticles (IONPs), concerns abound 
regarding their safety and possible toxicity arising from their intravenous administration with 
potential occurrences of toxic reactions[14,15] .For instance, supplementation of iron in 
patients with underlying dysfunctional Fe metabolism such as in thalassemia[16], increases 
the risk of cell necrosis due to the interplay between Fe and reactive oxygen species 
(ROS)[17]; with evidence suggesting toxicity due to Fe release following biodegradation of 
the Fe core in SPIONs[18], as well as reported cases of hypersensitivity by the Food and 
Drug Administration (FDA)[19] . 
To better explain the interaction of intravenously injected IONPs within the circulatory 
system, there is a need to investigate NP size changes that may occur in vivo, particularly 
within the period (24 h) reported for normal systemic clearance. Phagocytosis of IONPs from 
macrophages resident in the spleen and bone marrow as well as liver cells have been reported 
to be the operative mechanism responsible for the rapid clearance of IONPs from reticulo-
















of the injected IONPs; whether they undergo rapid transformation or slow dissolution in 
blood. From an analytical perspective, there is a need to study in vitro the influence and 
extent of sample matrix effect on a characterized ‘standard’ IONPs when it is spiked into 
blood. Dynamic light scattering (DLS) and electron microscopy have been used to 
characterize IONPs marketed as Ferumoxytol, a commercial IONP suspension [21]; with 
variable particle sizes reported for the core Fe and surrounding polysorbitol 
carboxymethylether (PSC) coating [22]. 
However, apart from generating images, these imaging and counting techniques do not 
provide enough reliable information with respect to changes in the size and form of the IONP 
during transport and interaction with matrix components in blood. In addition, conventional 
NP techniques such as TEM may in some cases be impeded by complex preparative 
techniques and sample matrix effects such as evaporation. More importantly, the high 
abundance of Fe in biological systems necessitates a need to employ a combination of 
techniques that combine separation, size characterization, as well as element specific 
detection capability. 
As previously acknowledged, no single technique can be applied to sufficiently identify, 
characterize and quantify NPs in a sample or scenario, rather a combination of techniques is 
required [23]. Asymmetric flow field-flow fractionation (AF4) is a gentle separation 
technique for the fractionation of NPs transported in a liquid carrier medium in a thin channel 
under the action of a perpendicular cross flow based on their diffusion coefficients, with a 
semi-permeable membrane acting as a an accumulation wall for the retention of 
nanoparticles[24,25]. The absence of a solid stationary phase enhances separation and reduces 
potential losses from analyte-column interactions. The AF4 fractionation system is equipped 
with a multi-angle light scattering (MALS) detector which has been applied for the accurate 
separation, particle size and molar mass characterization of polymers in drug delivery 
systems [26]. Multi-angle light scattering (MALS) detector generates a unique measurand for 
light scattering at various angles by individual particles of a macromolecule in solution 
known as the radius of gyration (Rg); defined as the root mean square distance of the object’s 
mass from either its centre of mass or a given axis[27]. Coupling of AF4-UV-MALS with 
online an element-specific detector such as inductively coupled plasma mass spectrometry 
(ICP-MS) is robust and has been extensively applied to provide highly needed elemental 
identification of fractionated NPs as a complement to particle size in a variety of sample 
















concentration of EMNPs in various sample matrices, provided that the artefacts, 
natural/background levels can be sufficiently differentiated from the target EMNPs. Use of 
radiolabelled or stable isotopes can overcome this challenge and enables the traceability of 
such labelled NPs in biological cells. However, some inherent shortcomings of this approach 
are the potential for radioactive contamination, need for special detectors and inability to 
conduct long-term studies when handling samples with short-half-life [31].  Another viable 
alternative is single particle ICP-MS (spICP-MS); which measures metallic NPs above high 
levels of natural/background dissolved analyte, enabling the detection of single particle 
signals as ‘pulses’ at very fast dwell times and ultra-low sample concentrations. In addition, 
with the destruction of the organic coating of the IONP in the ICP-MS plasma, the particle 
diameter of the ionized Fe-NP can be obtained without matrix interference [32,33]. In this 
study, AF4 was coupled with online UV-VIS, multi angle light scattering (MALS), and ICP-
MS detectors to characterise an IONP, as well to investigate potential size changes due to 
sample matrix effect. In addition, spICP-MS was applied to investigate potential size changes 
to the metallic (Fe) core of the NP due to matrix effects. The objective of the study was the 
detection and sizing of the IONP in its unaltered form with minimal sample preparation. The 
IONPs will be spiked into rat blood plasma and cellular fractions with 24 h incubation and 
NP size characterisation performed using AF4-UV-MALS-ICP-MS/MS, TEM and spICP-
MS. 
 
2. Material and methods 
2.1 Experimental 
2.1.1 Reagents and standards. All reagents used were of analytical grade or better, except 
where otherwise stated. A 30 mg mL
-1
 suspension of an engineered IONP (as Ferumoxytol
®
) 
was supplied by the Cardiovascular Imaging Research Group, Institute of Medical Sciences, 
University of Aberdeen. De-ionised ultrapure water (18.2 MΩ cm) from a Smart 2 Pure 
Millipore water system (Thermo Scientific, Sweden) was used for preparation of the mobile 
phases and blank solutions. The mobile phase for AF4 was 0.2% v/v Novachem surfactant 
(Postnova Analytics) in ultrapure water. The Novachem surfactant is a mixture of anionic and 
non-ionic surfactants with a stated composition [34].  The mobile phase was subsequently 
filtered under vacuum through a 0.22 µm cellulose acetate filter prior to use. The nebulization 
efficiency was determined by measuring a commercial AuNP standard suspension 


















 AuNP concentration. It was diluted 10
-6
 times with ultrapure water to yield a final 
working concentration of 50 ng kg
-1
. Dissolved Fe elemental standards (Accustandard, New 
Haven, USA) with a concentration of 1 µg kg
-1
 were prepared in ultrapure water from the 
stock solution of 10 mg L
-1
 and used to measure elemental response factors. 
 
2.1.2 Rat blood samples. Blood samples of adult rats were obtained from the Institute of 
Medical Sciences, University of Aberdeen and separated into plasma and cellular fractions by 
centrifugation. The cellular fractions were freeze dried for 12 hours (Heto Powerdry LL3000, 
Thermo Electron), and 50 mg fraction was dissolved in 10 mL of deionised water in acid 
washed sample tubes. Micro-sized particles were removed by filtering through a 0.45 µm 
syringe filter, and the filtrates were diluted with water.  
 
2.1.3 Spiking of samples with Ferumoxytol standard. A working suspension of the IONP 
as a standard was prepared by dilution of 30 mg mL
-1
 of Ferumoxytol to a final concentration 
of 0.150 mg mL 
-1
. Working solutions of the samples were prepared by spiking equivalent 
volume of diluted Ferumoxytol suspension respectively into 1 mL aliquots of plasma and 
cellular fractions and incubated at 37°C for 24 hours. 
2.1.4 Transmission electron microscopy (TEM). Samples were centrifuged for about 1 
min, and 5 µL of the suspension fixed onto circular, Formvar-coated copper films (200 mesh 
size) with a diameter of 3.05 mm. The TEM films were left to air-dry at ambient room 
temperature for 10 mins prior to analysis. 
2.1.5 Sample dilution (spICP-MS). To reduce the influence of soluble iron from 
haemoglobin which is naturally abundant in blood cells, micro-filtrates of the blood cell 
fraction were further centrifuged for 5 mins at 13,500 rpm and the supernatant was spiked 
with Ferumoxytol prior to dilution for spICP-MS. Ferumoxytol, plasma and filtered rat blood 
lysate samples were subsequently diluted to relevant concentrations with ultrapure deionised 
water. 
 
2.2 Instrumental analysis 
2.2.1 TEM. TEM images were acquired with a JEOL-1400 plus electron microscope, at an 
accelerating voltage of 80 kV, using an AMT UltraVUE camera. After image acquisition, 
they were filtered, and individual points counted as NPs using an open source image 
















diameters were calculated from areas of individual spheres and the data subsequently 
exported to Microsoft Excel to plot size frequency histograms. 
 
2.2.2 Coupling of AF4-UV-MALS to ICP-MS/MS. AF4 experiments were performed on 
an AF2000 MT system (Postnova Analytics, Landsberg, Germany). The separation system 
consisted of a solvent degasser, solvent organiser, two isocratic solvent pumps, a pair of 
Kloehn pumps for generation of the crossflow, an auto-sampler (PN 5300), and a separation 
channel. The separation channel was enclosed inside a thermostat consisting of a trapezoid 
cartridge, a ceramic frit and a spacer of 350 µm nominal height. Temperatures of 4°C and 
25°C were maintained for the auto-sampler and oven respectively. The fractionation system 
was coupled to a UV-Vis detector, a 21 angle multi-angle light scattering (MALS) detector 
and an online interface for connection to ICP-MS; all signals were monitored simultaneously. 




, with a 
laser light intensity of 50 mW and wavelength of 532 nm. Light scattering detectors were 
normalized by injecting a suspension of a mixture of 60 nm, 125 nm, and 350 nm latex beads. 
Light scattering data was recorded across all 21 angles but only the 90° signal was reported, 
except where stated otherwise, with UV-VIS absorbance monitored at 280 nm wavelength. A 
sample volume of 20 µL was used throughout the experiment, except where otherwise stated. 
Adequate membrane conditioning and reproducibility was achieved with a minimum of 
triplicate injections per sample.  Electronic signals generated from UV-VIS and MALS 
detectors were processed with the AF2000 software. Detailed AF4 elution conditions are 
shown in Table S1. ICP-MS/MS analysis was performed on an Agilent 8800 QQQ ICP-MS, 
fitted with a Micromist nebulizer and a double pass spray chamber. The ICP-MS/MS analysis 
parameters are outlined in Table S2. 
2.2.3 spICP-MS analysis. Single particle ICP-MS analysis was performed on an Agilent 
7900 ICP-MS equipped with a Micromist nebulizer and a double pass spray chamber. 
Nanoparticle signals were acquired at a dwell time of 100 µs. spICP-MS operating conditions 
are described in detail in Table S3. Instrumental parameters (lens position, torch position) 
were optimised daily to achieve maximum sensitivity with an aqueous tune solution of 
10 µg L
-1
 Li, Co, Y, Ce, Tl. Nanoparticle diameters for all the samples were reported as an 
average diameter of six replicates. Data analysis was performed using the Agilent 
MassHunter 4.4 software (Agilent Technologies, USA).  
 
















3.1 TEM: TEM is a conventional technique for the characterisation of NPs in biological 
specimens and has also been applied for the characterisation of IONPs [35]. However, a 
major constraint when analysing NP suspensions from a biological matrix using TEM are 
occasional low resolution images which are caused by the introduction of artefacts during the 
drying stage in the preparation of the TEM grid. Figure 1a indicates the presence of a cluster 
of spherical and random shaped structures in the pristine IONP which suggest the detection of 
IONPs. From the size frequency histogram, (Figure S1), the equivalent circular diameters of 











However, in the study by Wu et al. [22], IONPs as Ferumoxytol have been studied by both 
cryo-TEM and room temperature TEM showing diameters of between 5 to 9 nm prepared and 
measured with room temperature TEM; and an average hydrodynamic of diameter 25 nm 
obtained with DLS. Remarkably,  the study showed that Ferumoxytol consisted of a structure 
of iron core clusters, which are composed of several iron-carbohydrate particles. The cluster 
structures suggest that the PSC coating surrounding Ferumoxytol iron cores might be shared 
among different iron cores. The increased particle diameters of IONPs from Ferumoxytol 
measured in this study therefore appear to be related to this cluster structure, as well as 
possible introduction of artefacts during room temperature sample preparation. In the IONPs 
spiked into blood plasma (Figure 1b), there appears to be an increased number of  particles, 
with the dominance of irregularly shaped structures. However, size frequency histograms 
Figure 1. TEM images of pristine IONP (top left), IONPs spiked into rat blood plasma (top right) 


















(Figure S1) of the IONPs spiked into blood plasma showed a size population with equivalent 
circular diameter ranging from 15 nm to 50 nm (average diameter=18.0 ±5.2 nm).  A 
hypothesis for this observation is that the iron cluster structure facilitated by the carbohydrate 
coating has been altered and the IONPs have disintegrated into smaller sized particles. The 
TEM images also indicate a change from spherical to rod-like morphology for the particles, 
which are now more dispersed within the matrix.   
The TEM image from the IONPs spiked into blood cell sample (Figure 1c) showed a number 
of random shaped structures which appeared significantly larger than those seen in pristine 
IONP. The size frequency histogram of the spiked rat blood cell also resulted in a 
polydisperse size distribution with an average particle equivalent circular diameter of 111± 
14 nm (Figure S1).  The IONPs are suggested to form agglomerates which may be induced 
by magnetic attraction forces as shown in a similar study of superparamagnetic magnetite 
NPs spiked into calf serum [36]. Alternatively, it can also be suggested that the iron-
carbohydrate cluster structure contributes to formation of aggregates and the increase in the 
sizes, when compared with the TEM image of a blood cell devoid of IONPs which shows 





Figure 2. TEM image of a blood cell extract devoid of IONPs.  
 
Despite the lower image resolution characteristic of room temperature TEM compared with 
images obtained from advanced techniques such as cryo-TEM, the images provides some 
evidence that when the pristine IONPs were spiked into blood plasma their morphology was 
altered to show more rod-like morphology and the IONPs became more dispersed. The TEM 
















from both specimens it is challenging to confirm if these are aggregated NPs because of the 
limitation of a low resolution of TEM. The polymeric coating of the IONPs in this case PSC 
are surface active [37] and may cause bias during TEM analysis. Thus, to achieve more 
accurate characterisation using conventional TEM in a biological matrix, the application of  
advanced TEM techniques will provide an enhanced image resolution and reduce the 
possibility of artefact formation during sample preparation. 
 
3.2 AF4-UV-MALS coupling  to ICP-MS/MS: In brief, asymmetric flow field-flow 
fractionation (AF4) is a technique for the sequential separation of nanoparticles and colloids 
in a thin channel  under the action of a perpendicular crossflow. NPs are separated 
sequentially, eluting  in order of  increasing particle size and characterized as an ensemble by 
the UV and MALS detectors, while ICP-MS enables element specific detection. From FFF 
theory, retention time 𝑡𝑟  is directly proportional to particle hydrodynamic diameter 𝑑𝐻  as 
shown in the equation below [38]: 
 
      𝑑𝐻 = (
2𝑘𝑇𝐴
𝜋𝜂𝑉𝑐𝑤𝑡𝑜
) . 𝑡𝑟 
 
 
Where, 𝑑H= Particle hydrodynamic diameter, 𝑘 = Boltzmann constant, 𝑇 = Absolute 
temperature, 𝐴=Area of the accumulation wall, 𝑉𝑐= Cross flow rate, 
𝜂 = Viscosity of mobile phase, 𝑤 = Channel thickness, 𝑡𝑜 = void time, 𝑡𝑟 = Retention 
time. 
 
Though it was not applied in this study, the use of buffer solutions such as phosphate buffer 
saline (PBS) at physiological pH as AF4 mobile phases may appear suitable for biological 
samples but there are peculiar associated analytical problems such as salt precipitation which 
cause blockages in the AF4 system. The use of buffers as mobile phase in AF4 have been 
associated with loss of NP surface charge and aggregation [39,40]. As such, use of surfactant 
















recovery rates because they shield the NP from unwanted interactions with the membrane 
which is considered a bigger advantage than a potential disadvantage of particle size over-
estimation [41]. The same surfactant used in this study has been applied for previous AF4 
separation and characterisation studies of SPIONs [42,43]. 
The recovery rates (Table S3) and elution times of the pristine IONPS recorded with various 
crossflow programmes (1 mL min
-1
, 2 mL min
-1
, 3 mL min
-1
) were compared (UV-MALS 
and ICP-MS signals) to ascertain the optimal crosslow programme for the separation of 
IONPs (Figure S2 and Figure S3). Gigault et al. [44] consider an elution programme with a 
recovery rate of 70% to be adequate in an AF4 separation. From assumptions of FFF theory, 
membrane-particle interactions are absent during an ideal NP crossflow fractionation. In 
reality however, particles may be attracted and become irreversibly  attached to the 
membrane leading to sub-optimal recovery rates. The 1 mL min
-1
 elution programme showed 
the highest NP recovery rate (79%) and elution time (10 min)  for the pristine IONPs and 
therefore was applied for the characterisation of the pristine IONPs as a standard (Figure 3). 
Elution time differences of the IONPs for the 2 mL min
-1
 and the 3 mL min
-1
 crossflows were 
subtle; however 2 mL min
-1
 (R=74%) showed a higher recovery than 3 mL min
-1
 (R=69.5%). 
Also, all the three crossflow programmes showed an intense MALS peak at t0, suggesting 
some pre-elution of unfractionated particles. A possible cause for suboptimal recoveries of 
the injected IONPs was speculated to be due to membrane-particle interactions, which was 
investigated by measuring a blank as a wash-out step without crossflow after each injection 
of pristine IONPs using the different crossflow programmes (Figure S4). From MALS and 
ICP-MS signals, sample carry-over was detected for the crossflow programmes, the mass of 
Fe released was inversely proportional to the crossflow rate (Figure S2 -S4). However, the 2 
ml crossflow recorded the least intense UV-VIS peak at t0 (Figure S2a) and showed better 
















the 3 mL min
-1
 programme might be unsuitable to be used as an optimal crossflow rate in 
view of a higher possibility of membrane adhesion. Consequently, the 2 mL min
-1
 crossflow 
programme was considered as an optimal crossflow as a way to achieve a compromise 
between recovery rate and a gentle fractionation of the species. It was also considered it to be 
an optimal crossflow rate for the fractionation of any species that may be formed after the 
spiking of IONPs into blood fractions as it showed two well-resolved MALS peaks which 
may correspond to the iron and non-iron fraction respectively.  A random coil fit model was 
also applied for Rg computation because it showed an excellent fit across the 21 light 







Figure 3 illustrates the detection of UV-VIS and ICP-MS signals at 10 min, confirming that 
the fraction was an Fe-containing particle. However, MALS signal showed the elution of two 
peaks which are not clearly resolved between 10-20 min and 20-30 min respectively. The 
broken line (Figure 3b) indicates the separation between the two fractions; the peak eluting 
between 20 – 30 min was a non-iron containing peak and may be suggested to be part of the 
PSC coat. The radius of gyration obtained from integration of the light scattering signals 
using a random coil fit model showed a size range of between 15 nm and 28 nm (Rg=23 nm) 
Figure 3. AF4-UV-MALS-ICP-MS/MS fractograms showing the detection of Fe-containing 
particle in a pristine IONP sample using a 1 mL min
-1
 crossflow elution programme. The 
radius of gyration (b) of the IONPS were computed from MALS signals based on a random 
















for the first fraction while the 2
nd
 fraction showed a radius of gyration distribution  between 
30 nm to 75 nm (Rg =47.5 nm). Thünemann et al. [42] reported the characterisation of another 
commercial brand of SPIONs (Resovist) with AF4 coupled with small angle x-ray scattering 
(SAXS).  99% Particles displayed a bimodal size distribution, with 99 % particles in a radius 
of 4 – 13 nm, while 1% of the particles extended up to 21 nm. A bimodal distribution was 
clearly observed in this study using the 2 mL
-1
 and 3 mL
-1
 crossflow programmes. The 
MALS signal at t0 showed a higher intensity than UV-VIS which is speculated to indicate the 
elution of unfractionated particles at the start of the run. However, in both studies two 
different commercial brands of SPIONs were studied (Ferumoxytol vs. Resovist) which were 
composed of particle cores of magnetite (Fe3O4) and maghemite (γ-Fe2O3) respectively. 
Therefore, in view of possible subtle differences  in NP chemistry, it is challenging to draw a 






From Figure 4a, UV-VIS, MALS and ICP-MS signals were detected in the plasma sample 
spiked with Ferumoxytol at 6 min and at 10 min, suggesting that the IONP may have 
assumed a polydisperse form in the plasma sample matrix. A MALS peak at t0 (4.8 min) 
suggests the detection of a small number of unfractionated particles which have also been 
earlier observed in the fractionation of the pristine IONPs (Figure 3). The radius of gyration 
distribution between 6-10 min (Figure 4c) ranges between  40 nm-60 nm (average Rg = 
Figure 4. AF4-UV-MALS-ICP-MS/MS fractograms depicting the detection of IONPs spiked 
into rat blood plasma (a) and a non-spiked plasma sample (b). The radii of gyration 
distributions of NPs detected for IONPs spiked into plasma (c) and a non-spiked plasma 
sample (d) were computed from integration of MALS electronic signals based on a random 
















49 nm) which was likely composed of the original IONPs (detected at tr= 10 min). It can also 
be suggested that the IONPs have undergone some destabilisation resulting to a 
fragmentation of the IONPs. From 10 min to 30 min the MALS signal shows a broad peak, 
with an Rg of between 40 nm to 120 nm. The evidence from the MALS size distribution 
therefore suggests that the IONPs may have agglomerated after interaction with plasma 
proteins. Previous studies have reported that the abundant number of proteins in blood plasma 
bind to the surface of IONPs of different sizes [45]. The random coil fit model shows a good 
data fit which suggests that a non-spherical morphology for the IONPs when spiked into 
plasma thereby partially supporting the evidence provided with TEM images. However, the 
Rg values from MALS signals are far higher than the average diameters calculated from TEM 
images, which can be explained by the fact that TEM particle size determination from image 
treatment using Image J assumes a spherical morphology which yields an ‘equivalent circular 
diameter’, contrary to the actual visualisation of rod-like particles. Also, from a previous 
study [46] this discrepancy between TEM diameter and MALS Rg has been attributed to the 
influence of the encapsulating polymer coating (in this case polysorbitol carboxymethylether, 
PSC). However the low resolution of TEM in this study does not provide enough evidence 
for this assertion. 
In the non-spiked plasma sample (Figure 4d), intense UV-VIS, MALS and ICP-MS peaks 
were recorded at 6 min. ICP-MS signal suggests this to be small sized iron containing 
colloids in plasma (28-35 nm) , or erythrocytes which have been released from lysis during 
centrifugation of whole blood. In addition, the MALS signal between 20-30 min (Figure 4c) 
is elevated in the spiked sample compared to the non-spiked plasma sample (Figure 4d) 
showing a size  distribution of 50 nm – 120 nm, suggesting the detection of some non-iron 






















Figure 5. AF4-UV-MALS-ICP-MS fractograms showing the detection of IONPs into blood 
cells spiked into Ferumoxytol (a), and of non-spiked blood cells (b). Radii of distribution of 
IONPs spiked into blood cells (c) and of non-spiked blood cells which were computed from 
integration of MALS signals based on a random coil fit model.  
In the blood cells with spiked with Ferumoxytol (Figure 5a), ICP-MS and UV-VIS peaks 
were detected between 10 and 20 min with a peak maximum at 15 min, but a MALS signal 
was not detected. The UV-VIS peak was also of reduced intensity compared with the pristine 
IONPs.  Compared to the pristine IONPS (tr= 10 min), a slight shift in ICP-MS retention time 
(tr= 15 min) suggested that the IONPS may have interacted with the membrane in a different 
manner causing particle adhesion on the membrane. A low intensity MALS signal is an 
indication that the particles are below the detection limit of the MALS signal. Alternatively, 
this may also suggest that the core-shell structure of the IONP has become destabilised. In 
this manner, the carbohydrate coating appears to have disintegrated in the cellular matrix 
such that the exposed IONP core adheres to the membrane. Possible mechanism of adhesion 
could be related to electrostatic (attractive) forces, or magnetic effect. At t0 (5 min), intense 
UV-VIS, MALS and ICP-MS peaks were observed in the spiked blood cell sample which 
may be unfractionated particles or background iron-containing material.  
In the non-spiked cell sample, intense UV-VIS, MALS and ICP-MS peaks were also 
observed at t0, and are suggested to be cellular iron containing biomolecules in the blood cell 
matrix. However, MALS signal showed a broad peak dispersion between 20 min and 40 min 
with an Rg in the range 40 nm to 160 nm in both the non-spiked blood cell and spiked 
















material which remains unchanged with the injection of the IONPs. It can be suggested that 
the surface charge of the IONPs is shielded by the surfactant hydration layer which causes 
repulsion between the IONP and the endogenous biomolecules in the cellular matrix.  
 
3.3 Single particle ICP-MS. In spICP-MS analysis, samples must be sufficiently diluted 
and measured in fast time resolved analyis (TRA) mode using a short dwell time. When a 
single NP enters the plasma, a packet of ions is generated which creates a pulse signal on 
reaching the detector. The detector pulse is correlated to the total mass per particle, and 
subsequently correlated to the particle size [47]. The nebulisation efficiency [48,49], a key 
parameter for the determination of particle size distribution was obtained from analysis of a 
50 ng kg
-1 






Figure 6. Time scan of Fe signal for 150 ng kg-1 IONPs (Ferumoxytol), detected with sp-
ICP-MS using a 0.1 ms dwell time (a); particle size distribution of pristine IONPs (b) 
obtained using the MassHunter software showing a indicating a median particle diameter of 
28±3.2 nm. 
 
Processing of signals with the MassHunter software resulted to a median particle diameter of 
28±3.2 nm, which represented  the diameter of the metallic core of the IONP with a narrow 
distribution suggesting monodispersity (Figure 6). This value is mathematically equivalent to 
a radius of 14± 1.6 nm, which is less than the average gyration radius of 23 nm determined 
with MALS detector for the Fe-containing fraction of Ferumoxytol; which difference can be 
attributed to the PSC carbohydrate coating . The frequency size distribution (Figure 5b) 
indicated that the particles were ˂ 50 nm  which appears valid considering the 10 nm limit of 


















).  Despite such impressive LOSD, the 10 – 15 nm particles cannot be visualised on the 
histogram and are assumed to be detected alongside background noise signals. The LOSD 
indicates an improvement in the Dmin  of 55 nm for iron (as 
56
Fe), and 102 nm (as Fe3O4) 
using a dwell time of 10 milliseconds reported in a study by Lee et al. [50]. Two factors were 
responsible for lowering of the LOSD; use of collision cell technology (CCT) which reduces 
background noise (and instrument sensitivity), and a shorter dwell time which increases 
particle counting frequency and reduces the detector’s chance of omitting a particle. In this 
study, the collision cell was flushed with 3.5 mL min
-1
 of H2 gas to completely remove 




O species in ICP-MS argon plasma. Furthermore, a 
nebulizer gas flow rate of 0.79 L min
-1
 and a torch with 1.0 mm internal diameter were also 
used to minimise background noise. However, these measures were liable to cause a drop in 
instrumental sensitivity; but in the case of iron, a drop in sensitivity may be less impactful 
considering the high isotopic abundance of 
56
Fe (92%), and the overall high concentration of 
iron in the sample matrix. The use of a 0.1 millisecond dwell time in this study also causes a 
reduction of the LOSD and compensates for the drop in instrument sensitivity as shown in the 








Figure 7. Timescan of a blank sample (milli Q) measured at the start of the experiment to 
ascertain complete removal of interfering polyatomic species.  
 
The discrepancy between the particle radii of the pristine IONPs from spICP-MS (14 nm) 
and  MALS detector (23 nm) may be attributed to the presence of a hydration/corona layer 
around a particle in solution; however the Rg values may be over-estimated with the use of a 
surfactant based AF4 mobile phase. Considering that the pristine IONPs were engineered 
NPs and therefore monodisperse, a comparable particle diameter should be expected from 
spICP-MS and TEM analysis according to a previous study of engineered gold NPs by Pace 
et al. [33] which reported diameters of 37 nm and 42 nm using spICP-MS and TEM 
















MS median diameter (28 nm) and TEM average diameter (21 nm). Interestingly, spICP-MS 
diameter of the pristine IONPs correlated with the manufacturer’s nominal diameter of 30 nm 
which can be attributed to the high sensitivity of the spICP-MS technique such that the fast 





Figure 8. Time scan of Fe signal for rat plasma sample spiked with Ferumoxytol detected 
with spICP-MS using a 0.1 ms dwell time(a); particle size distribution of rat plasma sample 
(b) spiked with IONPs (Ferumoxytol), obtained using the MassHunter software showing a 
indicating a median particle diameter of 52 ± 0.8 nm. 
 
 
Figure 9. Time scan of Fe signal for a non-spiked rat plasma sample detected with spICP-MS 
using a 0.1 ms dwell time (a); particle size distribution of non-spiked rat plasma sample (b). 
An average median diameter of 25.8 ± 1.7 nm was detected which suggested a release of 
colloidal iron into the plasma from lysis of erythrocytes during possibly sample 
centrifugation. 
 
From Figure 8, spICP-MS analysis of rat blood plasma spiked with Ferumoxytol showed a 
median particle diameter of 52 ± 0.8 nm compared with that of pristine Ferumoxytol (28±3.2 
nm), indicating the detection of more larger sized NPs compared thereby suggesting the 
formation of large aggregates of Fe-NPs. The LOSD was 18 nm, which suggests an elevated 
background signal compared to the timescan of the pristine IONPs, which appears to reflect 
the capture of both small and big sized particles. It can be further argued that haemolysis 
during processing (centrifugation) releases natural Fe-containing colloids from erythrocytes 
into plasma; because the plasma sample was red instead of the regular straw colour of non-
haemolysed plasma [51,52] (Figure 9). This is indicated by the timescan (Figure 9a) and size 
distribution (Figure 9b) which suggests the presence of colloidal iron in the non-spiked 
plasma, though 
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). Comparison of the spICP-MS median diameter of 52 ± 0.8 
nm (mathematical radius of 26 ± 0.2 nm) with the average particle radius of 49 nm detected 
with MALS for IONPs spiked into plasma may suggest the presence of a corona or around 
the particle core estimated at 23nm. The average equivalent circular diameter (18 nm) of the 
IONPS spiked into plasma determined using TEM is lower than the spICP-MS value (52 
nm); a discrepancy attributed to the assumption of a spherical geometry for metallic NPs 
according to spICP-MS theory for the calculation of particle size. Contrarily, TEM images 
show the presence of non-spherical or rod-like particles thereby subjecting the spICP-MS 





 Figure 10. Time scan of Fe signal for rat blood cells spiked with IONPs (Ferumoxytol) 
detected with spICP-MS using a 0.1 ms dwell time. (b) Particle size distribution of rat blood 
cell fraction spiked with Ferumoxytol, otained with the Masshunter software indicating a 
median particle diameter of 33 ± 2.0 nm. 
 
In Figure 10,  the cell fraction spiked with Ferumoxytol showed  the detection of a median 
particle diameter of 33 ±2.0 nm, with a monodisperse distribution profile similar to that of 
pristine IONPs. Though the particle diameter suggested a slight increase in diameter of the 
iron core, it does not provide conclusive evidence for aggregation of the IONP. The LOSD 
was11.5 nm, suggesting an increased background signal which may associated with the 
sample matrix. Also, while the spICP-MS distribution profile is monodisperse, the weak 
MALS signal for the IONPs spiked into blood cells within the iron containing fraction 
prevents a comparison with the spICP-MS particle diameter.  The spICP-MS frequency 
















similar to the size distribution of the pristine IONPs; an evidence suggesting a minimal size 
alteration of the IONP in the blood cell fraction. Remarkably, the mean TEM average 
equivalent circular particle diameter 111± 14.5 nm obtained for IONPs spiked into cell 
fraction shows a discrepancy with the spICP-MS particle diameter. This may indicate that the 
equivalent circular diameters obtained from ImageJ data analysis  are incongruent with the 
actual shape of the particulate structures visualised in the TEM micrographs. Furthermore, 
TEM is a non-specific technique and endogenous natural NPs, colloids  and cellular debris 
may be mistaken for the IONP. Another possibility is that contrary to the theoretical 
assumptions of spICP-MS technique of a spherical geometry to calculate particle size, the 
geometry of the IONPs after their spiking into the blood cell are actually not spherical as seen 
from TEM images, hence calculated spICP-MS particle sizes may be subject to bias. Table 1 
summarises the particle sizes of the pristine IONPs and the sizes of the IONPs after spiking 
into rat blood plasma and cells using the different techniques applied in this study. 
 
 
Table 1. Summary of IONP particle sizes obtained with the different techniques 
 
Sample fraction TEM (Average particle 
diameter, nm) 
MALS (Average 





Pristine IONP 21  23 28 
IONP (plasma) 18 49 52 
IONP (cells) 110 - 33 


















This study has shed some light on the physico-chemical behaviour and characterisation of 
IONPs such as Ferumoxytol when injected into blood matrix. The characterization and 
applications of IONPs with various analytical techniques have been studied extensively 
[43,53-55]. For instance, Lohrke et al. [43] synthesised pristine SPIONs which they 
characterised using AF4-UV-MALS, DLS and TEM. However, this in vitro model with 
spiking experiments using AF4-UV-MALS-ICP-MS/MS combined with TEM and spICP-MS 
yet to be reported from available literature. TEM images shows that the cluster structure of 
the IONPs is altered in blood plasma and the IONPs become polydisperse. Despite the 
reported 24 h clearance rates of IONPs from reticulo-endothelial circulation (RES), there is 
previous experimental evidence showing that they may persist in trace amounts for an 
extended duration [56]. Studies by Lacava et al. [57] using mice have reported that injected 
dextran coated IONPs are cleared and stored in the liver and spleen from 1h and up to 6 
months after administration. We have demonstrated that using spICP-MS analysis, the 
concentration of the IONPs is high enough to be detected after 24 h incubation of the IONPs 
and complexity of the matrix. This may have implications for potential iron overload and risk 
of the formation of reactive oxygen species (ROS) though the Fenton reaction [58]. However, 
the exact biochemical transformations of injected IONPs in vivo cannot be fully explained 
with a spiking experiment. The use of a surfactant-based mobile phase as applied in this study 
for AF4 separation is known to enhance NP recovery by shielding surface charge by reducing 
membrane adhesion and NP aggregation; however they are prone to cause an overestimation 
of particle sizes and micelle formation which are potential sources of measurement bias.  A 
low intensity MALS signal for the IONPs in blood cell suggested a possible dissolution of the 
NP carbohydrate coating which prevented size determination of the IONPs spiked into blood 
cell. Thus, it was not possible to understand the precise nature of the possible size and surface 
















and toxicity arising from the intravenous administration of IONPs and other intravenous iron 
products in humans [15,59]. 
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 A monodisperse distribution was obtained for pristine iron oxide NPs. 
 TEM showed that IONPs were polydisperse when spiked into blood plasma. 
 A weak MALS signal for IONPs spiked in blood cell suggested NP loss. 
 IONPs sizes in plasma were affected by colloidal Fe release by cell lysis. 
 spICP-MS indicated that NP size changes was due to sample matrix effects. 
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